Judit Svensson-Arvelund

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.

Judit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia

|Dec 18, 2020
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Ranjan Upadhyay, Jonathan A Boiarsky, Gvantsa Pantsulaia

|Aug 04, 2019
Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade.

Netonia Marshall, Keino Hutchinson, Thomas U Marron

|May 25, 2019
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection.

Mark Aleynick, Judit Svensson-Arvelund, Christopher R Flowers

|Jan 07, 2015
The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages.

Judit Svensson-Arvelund, Ratnesh B Mehta, Robert Lindau

Pageof 1